Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a Novel Oncogenic Fusion Gene SPON1-TRIM29 in Clinical Ovarian Cancer That Promotes Cell and Tumor Growth and Enhances Chemoresistance in A2780 Cells

8 Jan 2022

Abstract excerpt

Gene structure alterations, such as chromosomal rearrangements that develop fusion genes, often contribute to tumorigenesis. It has been shown that the fusion genes identified in public RNA-sequencing datasets are mainly derived from intrachromosomal rearrangements. In this study, we explored fusion transcripts in clinical ovarian cancer specimens based on our RNA-sequencing data. We successfully identified an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to interferon and immune responses
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35054873
DOI: 10.3390/ijms23020689

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a Novel Oncogenic Fusion Gene SPON1-TRIM29 in Clinical Ovarian Cancer That Promotes Cell and Tumor Growth and Enhances Chemoresistance in A2780 CellsPMID 35054873Read ↗

Investigation of novel regulatory mechanisms of TRIM29 in BC, GC, and CRC patients: systems biology approach to find novel non-coding interactionsSemantic proximity Read ↗

Fusion genes in gynecologic tumors: the occurrence, molecular mechanism and prospect for therapySemantic proximity Read ↗

High expression of TRIM29 (ATDC) contributes to poor prognosis and tumor metastasis by inducing epithelial-mesenchymal transition in osteosarcomaSemantic proximity Read ↗

m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells.Semantic proximity Read ↗

TRIM29 functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer.Semantic proximity Read ↗

Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes.Semantic proximity Read ↗

Increased TRIM31 gene expression is positively correlated with SARS-CoV-2 associated genes TMPRSS2 and TMPRSS4 in gastrointestinal cancersSemantic proximity Read ↗

TRIM28 in cancer and cancer therapySemantic proximity Read ↗

Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumorsSemantic proximity Read ↗

The complexity of TRIM28 contribution to cancerSemantic proximity Read ↗

Identification of recurrent fusion genes across multiple cancer typesSemantic proximity Read ↗

SOX30, a valuable diagnostic marker, suppresses tumor growth via inducing autophagy as key cadres in ovarian cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.